This list of pharmaceutical compound number prefixes details a drug labeling standard. Pharmaceutical companies produce a large number of compounds. The compounds are systematically numbered, such as CP-529414 (for the recently failed Pfizer experimental drug torcetrapib). In addition to the number, there are several letters (the "prefix") that usually tells which company the compound comes from. Since the pharmaceutical industry has gone through a lot of mergers and acquisitions, the original company and the current company are both listed. [edit] A to F - ABT - Abbott Labs
- ACP - Acadia Phamarceuticals
- ACZ - Novartis
- Example: ACZ-885, an experimental drug for Arthritis [1]
- ADL - Adolor Corporation [2]
- AG - Agouron, now Pfizer La Jolla Labs
- AGI - AtheroGenics
- AH - Amersham plc (Amersham Health)
- ALS - Alantos Pharmaceuticals, acquired by Amgen in June 2007
- Example: ALS 2-0426, an experimental drug for diabetes
- ANX - Adventrx Pharmaceuticals [3]
- AMG - Amgen
- ARQ - ArQule
- ATL - Antisense Therapeutics Limited, Australia [4]
- AZD - AstraZeneca
- BMS - Bristol-Myers Squibb
- Example: BMS-562247 or apixaban, an experimental anti-coagulant drug targeting Factor Xa
- BRL - Beecham Research Labs, merged with SmithKline into SmithKline Beecham which merged into GlaxoSmithKline
- CAT - Cannasat Therapeutics Inc.
- CE - Pfizer
- CGS - Ciba Geige
- CP - Pfizer Groton. CP probably refer to the founder of the company, Charles Pfizer
- Example: CP-751871, an experimental cancer drug for non-adenocarcinoma
- CSL - CSL Ltd, an Australian Biophamaceutical company
- DMP - DuPont Merck Pharmaceuticals, a joint venture between DuPont and Merck, turns to DuPont Pharmaceuticals in 1998
- DPC - DuPont Pharmaceuticals, acquired by Bristol-Myers Squibb in 2001
- Example: DPC-906, or razaxaban, an experimental anti-coagulant drug targeting Factor Xa
- ETC - Esperion Therapeutics, acquired by Pfizer in 2003
[edit] G to L [edit] M to S - MCN - McNeil Laboratories, now part of Johnson & Johnson
- MEM - Memory Pharmaceuticals
- MGX - Victory Pharma (this is questionable, the letters don't make sense)
- MK - Merck
- MLN - Millennium Pharmaceuticals
- NC - Nycomed
- NCX - NicOx, a French Biotech
- NG - Neurogen Corp.
- OGX - OncoGenex
- OPC - Otsuka Pharmaceutical Co.
- PD - Parke-Davis, now Pfizer
- PF - Pfizer
- Example: PF-3512676, an experimental drug for cancer
- PHA - Pharmacia, now Pfizer
- R - Janssen Pharmaceutica, now part of Johnson & Johnson
- RO - Hoffmann-La Roche
- RU - Roussel Uclaf
- RWJ - R.W. Johnson Pharmaceutical Research, now part of Johnson & Johnson
- SAN - Sandoz Pharmaceuticals, now Novartis
- SB - SmithKline Beecham, now GlaxoSmithKline
- SCH - Schering-Plough
- SPI - Spectrum Pharmaceuticals Inc.
- SU - Sugen, now Pfizer
- Example: SU-11248 (sunitinib malate) or Sutent, an FDA approved cancer drug
[edit] T to Z - TAK - Takeda
- Example: TAK-491, an experimental drug for hypertension
- TC - Targacept Inc.
- TG - Tragara Pharmaceuticals Inc. San Diego, CA
- TKS - Thiakis Limited, a UK biotech company (acquired by Wyeth in 2008)[6].
- Example: TKS-1225, experimental drug for obesity.
- TM - TransMolecular, Inc. [7]
- Example: TMC125, experimental HIV drug targeting NNRTI
- TMC - Tibotec Pharmaceuticals
- TNP - Takeda Neosplastic Product, from Takeda Pharmaceutical Company, Japan
- Example: TNP-470, an antiangiogenesis agent, analog of fumagilin
- TS - Taisho Pharmaceutical Co., a Japanese Pharmaceutical Company [8]
- UK - Pfizer Sandwich, UK
- VX - Vertex Pharmaceuticals
- XL - Exelexis
- Example: XL-281, an experimental cancer drug [9]
- XTL - XTL Biopharmaceuticals
- XU - Sandoz Pharmaceuticals, now Novartis
- Example: XTL-2125, an experimental drug for hepatitis C, failed in phase I in June 2007
[edit] References |
